As Of	Filer	Filing¹	For·On·As	Docs:Size	Issuer		Filing Agent

 3/10/14  Jebsen Michael B                  4          Officer²    1:4K   Tenax Therapeutics, Inc.                                   
 1/22/14  Tenax Therapeutics, Inc.          8-K/A:9    11/13/13    5:2.6M                                   Issuer Direct/FA         
11/19/13  Tenax Therapeutics, Inc.          8-K:2,3,5,911/13/13    5:391K                                   Issuer Direct/FA         
11/15/13  Kelley John P                     4          Officer²    1:5K   Tenax Therapeutics, Inc.          Issuer Direct/FA         
11/15/13  Kelley John P                     3          Officer²    1:3K   Tenax Therapeutics, Inc.          Issuer Direct/FA         

____________
¹	Filing/Form Types:
	3	Initial Statement of Beneficial Ownership of Securities by an Insider — Form 3 { The Filer is an Insider² of the Issuer }.
	4	Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 { The Filer is an Insider² of the Issuer }.
	8-K	Current Report — Form 8-K { Item 1: Business & Operations;  2: Financial Info;  3: Securities & Trading;  4: Accountants & Accounting;  5: Governance & Management;  6: Asset-Backed Securities;  7: Disclosures;  8: Events;  9: Financials }.
	/A	Amendment to, or Amended version of, a previous Filing of this Type.
²	Insider:  The Filer is a Director, Officer, 10% Owner and/or Other “insider” of the Issuer.